Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care
2 other identifiers
interventional
208
1 country
1
Brief Summary
This randomized controlled trial will assess the effects on quality of life of two approaches to symptom management among new patients referred to a palliative care oncology clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Nov 2022
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2022
CompletedFirst Posted
Study publicly available on registry
April 15, 2022
CompletedStudy Start
First participant enrolled
November 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
November 28, 2025
February 1, 2025
3.7 years
April 1, 2022
November 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of Life - McGill Quality of Life Questionnaire
Quality of life will be measured through the McGill Quality of Life Questionnaire Revised (MQOL-R). The questionnaire is 15 questions assessing overall and specific areas of quality of life.
Baseline - 16 weeks
Secondary Outcomes (6)
Feasibility of Accessing Additional Resources for Symptom Management
Baseline - 16 weeks
Acceptability of Accessing Additional Resources for Symptom Management
Baseline - 16 weeks
Symptom Severity
Baseline - 16 weeks
Medication Use
Baseline - 16 weeks
Hospital-Free Days
Baseline - 16 weeks
- +1 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALParticipants in this group will consent to participate in a study about quality of life for patients with cancer seeking outpatient palliative care. They will be seen in a palliative care oncology clinic at which time they will be offered additional resources to promote symptom management. They will be asked to complete a series of surveys every two weeks for 16 weeks which will assess their quality of life, symptoms, and medication use.
Usual Care
NO INTERVENTIONParticipants in this group will consent to participate in a study about quality of life for patients with cancer seeking outpatient palliative care. They will be seen in a palliative care oncology clinic where they will receive symptom management and supportive care. They will be asked to complete a series of surveys every two weeks for 16 weeks which will assess their quality of life, symptoms, and medication use.
Interventions
Participants will be offered additional resources to promote symptom management.
Eligibility Criteria
You may qualify if:
- Be a new patient at an outpatient palliative care clinic
- Resident of Pennsylvania
- Over 18 years of age
You may not qualify if:
- Prior use of certain symptom focused therapies
- Currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
April 1, 2022
First Posted
April 15, 2022
Study Start
November 3, 2022
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
November 28, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share